Document is current
Any future updates will be listed below
-
Authors
Cui, Hui Xing
Liu, Jun Xian
Kang, Young Cheol
Han, Kyuboem
Lee, Hong Kyu
Kim, Chun-Hyung
Zhang, Yin Hua
-
Funding
Funding for this research was provided by:
Korean National Research Foundation of Korea (NRF) grant (NRF-2019R1A2C1005720, NRF-2023R1A2C1005720)
BK21 FOUR education program, Korean Society of Hypertension (Grant number KSH-R-2020)
National Natural Science Foundation of China (NSFC 31660284, NSFC31860288)
- License Information
-
More Information
Article History
Received: 12 August 2025
Accepted: 2 February 2026
First Online: 13 February 2026
Declarations
:
: All animal experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the Laboratory Animal Centre, Seoul Medical University, South Korea [SNU-220724-1-1] (A Study on Cardiovascular Mechanisms and Treatment in Preeclamptic Pregnant Rats; the experimental period is from January 16, 2023, to January 16, 2024.) Primary culture and the use of hUC-MSCs from a healthy pregnant woman were approved with informed consent. The study was approved by Public Institutional Review Board (IRB) designated by Ministry of Health and Welfare, Korea (IRB No. P01-202002-31-008). This license is granted to Paean Biotechnology, Inc., Republic of Korea.
: This work was reported in accordance with the ARRIVE 2.0 guidelines.
: No works generated by artificial intelligence were used in this article.
: The authors declare no competing interests.
